 NEWARK, Calif., Nov. 4, 2020 PRNewswire -- Protagonist Therapeutics, Inc. NASDAQ: PTGX today announced the acceptance of one oral and four poster presentations at the American Society for Hematology ASH annual meeting, taking place in a virtual format December 5-8, 2020. The... 